• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名患有III型蛋白S缺乏症且在孕期发生静脉血栓形成的年轻女性的蛋白S基因突变

Protein S gene mutation in a young woman with type III protein S deficiency and venous thrombosis during pregnancy.

作者信息

Hirose Masaya, Kimura Fuminori, Wang Hua-Qin, Takebayashi Koichi, Kobayashi Masashi, Nakanishi Keiko, Akiyama Minoru, Kimura Toshio, Noda Yoichi

机构信息

Department of Obstetrics and Gynecology, Shiga University of Medical Science, Ohtsu, Japan.

出版信息

J Thromb Thrombolysis. 2002 Apr;13(2):85-8. doi: 10.1023/a:1016294730165.

DOI:10.1023/a:1016294730165
PMID:12101385
Abstract

BACKGROUND

We attempted to identify a gene defect in a young woman with type III protein S deficiency and venous thrombosis during pregnancy.

METHODS

Measurements of total and free PS antigen levels in plasma were carried out using an enzyme-linked immunosorbent assay. Plasma PS cofactor activity was determined by a clotting assay using activated factor V as the substrate. Genomic DNA prepared from peripheral blood was amplified by polymerase chain reaction (PCR) with PROS1-specific oligonucleotide primers. PCR products were sequenced on both strands using specific oligonucleotide primers.

RESULTS

Plasma PS cofactor activity was undetectable in every measurement at 36 weeks of gestation, as well as at 2 weeks and 4 months after delivery. Plasma total PS antigen levels were 70% and 67% at 2 weeks and 4 months after delivery, respectively. Free PS antigen level was 24% at 4 months after delivery. Of all exons analyzed, codon 295 of GGC in exon 10 was substituted for AGC. This missense mutation predicted an amino acid change of glycine to serine.

CONCLUSIONS

Measurements of total and free PS antigen levels along with PS activity indicated that this was a case of type III PS deficiency. DNA analysis identified a heterozygous missense mutation of codon 295 in the PS gene, substituting glycine for serine.

摘要

背景

我们试图在一名患有III型蛋白S缺乏症且在孕期发生静脉血栓形成的年轻女性中鉴定基因缺陷。

方法

采用酶联免疫吸附测定法检测血浆中总蛋白S和游离蛋白S抗原水平。以活化因子V为底物,通过凝血测定法测定血浆蛋白S辅因子活性。使用PROS1特异性寡核苷酸引物,通过聚合酶链反应(PCR)扩增从外周血制备的基因组DNA。使用特异性寡核苷酸引物对PCR产物的两条链进行测序。

结果

在妊娠36周时以及分娩后2周和4个月的每次检测中均未检测到血浆蛋白S辅因子活性。分娩后2周和4个月时血浆总蛋白S抗原水平分别为70%和67%。分娩后4个月时游离蛋白S抗原水平为24%。在所有分析的外显子中,第10外显子中GGC的第295密码子被替换为AGC。这种错义突变预测甘氨酸会变为丝氨酸。

结论

总蛋白S和游离蛋白S抗原水平以及蛋白S活性的检测表明,这是一例III型蛋白S缺乏症病例。DNA分析鉴定出蛋白S基因中第295密码子存在杂合错义突变,导致甘氨酸被丝氨酸替代。

相似文献

1
Protein S gene mutation in a young woman with type III protein S deficiency and venous thrombosis during pregnancy.一名患有III型蛋白S缺乏症且在孕期发生静脉血栓形成的年轻女性的蛋白S基因突变
J Thromb Thrombolysis. 2002 Apr;13(2):85-8. doi: 10.1023/a:1016294730165.
2
[Recurrent deep vein thrombosis caused by heterozygous missense mutation of the protein S gene: genetic analysis of a case].[蛋白S基因杂合错义突变导致复发性深静脉血栓形成:1例病例的基因分析]
Nan Fang Yi Ke Da Xue Xue Bao. 2011 Jun;31(7):1228-31.
3
Genetic and phenotypic variability between families with hereditary protein S deficiency.遗传性蛋白S缺乏症家族之间的遗传和表型变异性。
Thromb Haemost. 2002 Feb;87(2):258-65. doi: 10.1055/s-0037-1612982.
4
Two Novel Variants in the Protein S Gene PROS1 Are Associated with Protein S Deficiency and Thrombophilia.两个蛋白 S 基因 PROS1 中的新型变异与蛋白 S 缺乏和血栓形成倾向相关。
Acta Haematol. 2021;144(2):222-226. doi: 10.1159/000508525. Epub 2020 Jul 10.
5
Compound heterozygous mutations identified in severe type I protein S deficiency impaired the secretion of protein S.鉴定出严重型 I 型蛋白 S 缺乏症中的复合杂合突变,损害了蛋白 S 的分泌。
J Clin Pathol. 2020 Jan;73(1):7-13. doi: 10.1136/jclinpath-2019-205956. Epub 2019 Aug 17.
6
One novel and one recurrent mutation in the PROS1 gene cause type I protein S deficiency in patients with pulmonary embolism associated with deep vein thrombosis.PROS1基因中的一个新突变和一个复发突变导致与深静脉血栓形成相关的肺栓塞患者出现I型蛋白S缺乏症。
Am J Hematol. 2006 Oct;81(10):787-97. doi: 10.1002/ajh.20689.
7
Superior mesenteric venous thrombosis associated with a familial missense mutation (Pro626Leu) in the SHBG-like domain of the protein S molecule.
Int J Hematol. 2002 Jan;75(1):100-3. doi: 10.1007/BF02981988.
8
Four missense mutations identified in the protein S gene of thrombosis patients with protein S deficiency: effects on secretion and anticoagulant activity of protein S.在蛋白S缺乏的血栓形成患者的蛋白S基因中鉴定出的四个错义突变:对蛋白S分泌和抗凝活性的影响
Thromb Res. 2002 Feb 1;105(3):233-9. doi: 10.1016/s0049-3848(02)00015-4.
9
Clinical Manifestation and Mutation Spectrum of 53 Unrelated Pedigrees with Protein S Deficiency in China.中国 53 个无血缘关系的蛋白 S 缺乏症家系的临床表现和突变谱。
Thromb Haemost. 2019 Mar;119(3):449-460. doi: 10.1055/s-0038-1677031. Epub 2019 Jan 22.
10
Molecular basis for protein S hereditary deficiency: genetic defects observed in 118 patients with type I and type IIa deficiencies. The French Network on Molecular Abnormalities Responsible for Protein C and Protein S Deficiencies.蛋白S遗传性缺乏症的分子基础:118例I型和IIa型缺乏症患者中观察到的基因缺陷。法国蛋白C和蛋白S缺乏症分子异常研究网络。
J Lab Clin Med. 1996 Aug;128(2):218-27. doi: 10.1016/s0022-2143(96)90015-3.

引用本文的文献

1
Activated protein C anticoagulant system dysfunction and thrombophilia in Asia.亚洲人群的活化蛋白 C 抗凝系统功能障碍与血栓形成倾向
Ann Lab Med. 2013 Jan;33(1):8-13. doi: 10.3343/alm.2013.33.1.8. Epub 2012 Dec 17.

本文引用的文献

1
Genetic susceptibility to venous thrombosis.静脉血栓形成的遗传易感性。
N Engl J Med. 2001 Apr 19;344(16):1222-31. doi: 10.1056/NEJM200104193441607.
2
Changes in the plasma activities of protein C and protein S during pregnancy.孕期蛋白C和蛋白S的血浆活性变化。
Aust N Z J Obstet Gynaecol. 2000 Nov;40(4):448-50. doi: 10.1111/j.1479-828x.2000.tb01179.x.
3
Protein S deficiency: a database of mutations--summary of the first update.蛋白S缺乏症:突变数据库——首次更新总结
Thromb Haemost. 2000 Nov;84(5):918.
4
Protein C deficiency related to valproic acid therapy: a possible association with childhood stroke.与丙戊酸治疗相关的蛋白C缺乏:与儿童中风的可能关联。
J Pediatr. 2000 Nov;137(5):714-8. doi: 10.1067/mpd.2000.108565.
5
Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial.低剂量阿司匹林预防肺栓塞和深静脉血栓形成:肺栓塞预防(PEP)试验
Lancet. 2000 Apr 15;355(9212):1295-302.
6
Screening for aetiology of thrombophilia: a high prevalence of protein S abnormality.
Ann Clin Biochem. 1999 Jul;36 ( Pt 4):423-32. doi: 10.1177/000456329903600404.
7
Thrombosis in pregnancy: maternal and fetal issues.妊娠期血栓形成:母体和胎儿问题
Lancet. 1999 Apr 10;353(9160):1258-65. doi: 10.1016/S0140-6736(98)10265-9.
8
Three novel missense mutations in unrelated Japanese patients with type I and type II protein S deficiency and venous thrombosis.在患有I型和II型蛋白S缺乏症及静脉血栓形成的互不相关的日本患者中发现的三种新的错义突变。
Thromb Res. 1998 Feb 15;89(4):151-60. doi: 10.1016/s0049-3848(97)00311-3.
9
Identification of 19 protein S gene mutations in patients with phenotypic protein S deficiency and thrombosis. Protein S Study Group.表型蛋白S缺乏症和血栓形成患者中19种蛋白S基因突变的鉴定。蛋白S研究组。
Blood. 1996 Dec 1;88(11):4195-204.
10
Clinically important drug interactions with anticoagulants. An update.与抗凝剂相关的具有临床重要意义的药物相互作用。最新进展。
Clin Pharmacokinet. 1996 Jun;30(6):416-44. doi: 10.2165/00003088-199630060-00002.